BD

Babli Devi

Active Director Director DIN 08623572
DIN 08623572 First appointment Nov 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Babli Devi

Data last updated:

Babli Devi is a Director at Humannovo Life Science Private Limited (since 2019). The company operates in Chemicals.

DIN 08623572
Primary Designation Director
Industry Chemicals
First Appointment 27 Nov 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Nov 20192019Active

Board colleagues of Babli Devi

NameDINCompanyDesignation
Astha08623571Humannovo Life Science Private LimitedDirector
Sumit Kumar Kesarwani08692134Humannovo Life Science Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Humannovo Life Science Private Limited
Premium access

Shareholding and investment profile for Babli Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babli Devi

Babli Devi currently holds 1 directorship: Humannovo Life Science Private Limited (Director, since 27 Nov 2019).

Babli Devi was first appointed on 27 Nov 2019 as Director at Humannovo Life Science Private Limited.

The current boards of Babli Devi's companies include Astha (Humannovo Life Science Private Limited), Sumit Kumar Kesarwani (Humannovo Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available